Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
Kiniksa Pharmaceuticals, Ltd. reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Kiniksa Pharmaceuticals, Ltd. reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, four executives at Kiniksa Pharmaceuticals, Ltd. received on average a compensation package of $2.6M, a 37% decrease compared to previous year.
Average pay of disclosed executives at Kiniksa Pharmaceuticals, Ltd.
Sanj K. Patel, Chief Executive Officer, received $4.8M in total, which decreased by 35% compared to 2018. 74% of Patel's compensation, or $3.5M, was in option awards. Patel also received $456K in non-equity incentive plan, $780K in salary, as well as $11K in other compensation.
Stephen Mahoney, Chief Operating Officer, received a compensation package of $2.7M, which increased by 1% compared to previous year. 56% of the compensation package, or $1.5M, was in option awards.
John F. Paolini, Chief Medical Officer, earned $1.5M in 2019, a 39% decrease compared to previous year.
Qasim Rizvi, Senior Vice President, Operations and Chief Commercial Officer, received $1.5M in 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2020.